# Safety and Tolerability of the Ophthalmic Solution PRO-179 Compared With Travatan®

> **NCT03965052** · PHASE1 · COMPLETED · sponsor: **Laboratorios Sophia S.A de C.V.** · enrollment: 24 (actual)

## Conditions studied

- Glaucoma

## Interventions

- **DRUG:** PRO 179
- **DRUG:** Travatan 0.004 % Ophthalmic Solution

## Key facts

- **NCT ID:** NCT03965052
- **Lead sponsor:** Laboratorios Sophia S.A de C.V.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-24
- **Primary completion:** 2019-07-02
- **Final completion:** 2019-08-29
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2019-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03965052

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03965052, "Safety and Tolerability of the Ophthalmic Solution PRO-179 Compared With Travatan®". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03965052. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*